# A Clinical Trial to Evaluate the HeartWare MVAD® System (MVAdvantage)

> **NCT01831544** · NA · TERMINATED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 11 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** HeartWare MVAD® System

## Key facts

- **NCT ID:** NCT01831544
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07-14
- **Primary completion:** 2015-09-01
- **Final completion:** 2017-02-16
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Recruitment terminated due to higher rate of thrombosis events than expected.
- **Last updated:** 2025-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01831544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01831544, "A Clinical Trial to Evaluate the HeartWare MVAD® System (MVAdvantage)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01831544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*